Holen Sie sich die Stockscreener-App
15.63
1.20%
-0.19
Handel nachbörslich:
15.80
0.17
+1.09%
Schlusskurs vom Vortag:
$15.82
Offen:
$15.65
24-Stunden-Volumen:
25.29M
Relative Volume:
1.21
Marktkapitalisierung:
$3.56B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
22.65
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
-4.11%
1M Leistung:
-48.70%
6M Leistung:
-63.97%
1J Leistung:
-76.46%
1-Tages-Spanne:
$15.29
$16.30
1-Wochen-Bereich:
$15.29
$16.92
52-Wochen-Spanne:
$15.29
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
15.63 | 3.60B | 1.78B | 164.40M | 236.51M | 0.69 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.66 | 58.95B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.78 | 53.73B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
11.27 | 49.47B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.22 | 39.98B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.42 | 20.69B | 3.13B | 1.27B | 1.12B | 26.39 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-12 | Eingeleitet | Evercore ISI | In-line |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-21 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Key deals this week: Visa, Hims & Hers Health, Salesforce and more (KW:NYSE) - Seeking Alpha
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside - MarketBeat
Super Micro Computer, Blue Owl, Hims & Hers And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week - Finviz
Novo Nordisk Stock Investors Just Got Great News From Eli Lilly - AOL.com
Hims & Hers Goes Global While GLP-1 Drama Plays Out at Home - Athletech News
HIMS Shows Mixed Options Sentiment as Earnings Approach - GuruFocus
Deal Dispatch: Starboard Targets TripAdvisor, His & Hers Expands, Mister Car Wash Goes Private - Benzinga
Earnings Outlook For Hims & Hers Health - Benzinga
Hims & Hers Accelerates AI Preventive Care and Platform Strategy - Nasdaq
Hims & Hers HUGE Acquisition News! - AOL.com
BIT Capital GmbH Has $125.37 Million Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Makes Billion-Dollar Bet on Global Growth - AD HOC NEWS
Hims & Hers Buying Eucalyptus For Up To $1.15B - Law360
San Francisco telehealth company commits more than $1 billion to international expansion - The Business Journals
Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B - HIT Consultant
Analysis-Hims & Hers GLP-1 pill gambit backfires, accelerating crackdown on drug compounders - Westlaw Today
Overlooked and Undervalued: Why Novo Nordisk Stock Deserves Attention - AOL.com
Is Viking Therapeutics Stock Really Going to $125? - AOL.com
Hims & Hers Enters $1.15 Billion Agreement to Acquire Eucalyptus - Pharmaceutical Executive
Hims & Hers Looks to Expand Globally With Buy of Australian Telehealth Provider - Barron's
Hims & Hers to Acquire Eucalyptus in $1.15 Billion Deal - GuruFocus
Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerat - GuruFocus
Hims & Hers continues global expansion with $1.15B acquisition - TechTarget
Hims & Hers to Acquire Eucalyptus in Deal Valued Up to $1.15B - GuruFocus
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Acquires Australian Telehealth Company, Eucalyptus, for $1.15 Billion - MLQ.ai
M&A News: Hims & Hers (HIMS) Expands Globally with $1.15B Eucalyptus Buyout ahead of Q4 Earnings - TipRanks
Can Platform Strength Support Hims & Hers Stock Before Q4 Earnings? - TradingView
Hims & Hers Health Stock Resumes Climb on Acquisition News - Schaeffer's Investment Research
Hims & Hers Health (HIMS) Rises on Eucalyptus Acquisition - GuruFocus
Hims plans to acquire Eucalyptus for up to $1.15B - Axios
Hims & Hers (HIMS) Stock: Company Acquires Eucalyptus for Up to $1.15 Billion - Blockonomi
What Is HIMS Worth Without GLP-1? Earnings Preview (NYSE:HIMS) - Seeking Alpha
4 stocks to watch on Thursday: HIMS, DPZ, WMT, PSX - Seeking Alpha
Why Is Hims & Hers Health Stock Trading Higher Today?Hims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers under fire over copycat weight loss drugs - AOL.com
Hims & Hers to acquire Eucalyptus for up to $1.15 billion - Investing.com
Hims & Hers Health (HIMS) to Acquire Eucalyptus in $1.15 Billion Deal - GuruFocus
Hims & Hers is spending more than $1 billion in a push to expand globally - MarketWatch
Hims & Hers to acquire Australian digital health firm Eucalyptus, expanding international footprint - Proactive financial news
US FDA says Novo's obesity pill TV Ad is false or misleading - AOL.com
US Premarket Movers: Carvana, Deere, Hims & Hers, Walmart - Bloomberg.com
Forget Ozempic: This Obesity‑Drug Giant Is Grabbing the Biggest Slice of the GLP‑1 Gold Rush - AOL.com
Hims & Hers Health to acquire Australia’s Eucalyptus for up to $1.15 billion - 1470 & 100.3 WMBD
Hims & Hers Stock Jumps on $1.15 Billion Deal to Acquire Australian Telehealth Provider - Barron's
Hims & Hers to Acquire Eucalyptus in Global Expansion - TipRanks
Hims & Hers Jumps Premarket After $1.15B Global Expansion Deal - Tokenist
Why Hims & Hers Stock Is Sliding Today - TipRanks
Hims & Hers stock rises after agreement to acquire Eucalyptus By Investing.com - Investing.com Australia
Hims & Hers stock rises after agreement to acquire Eucalyptus - Investing.com UK
Hims & Hers to buy Australian digital health firm Eucalyptus for over $1B - Seeking Alpha
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hims Hers Health Inc-Aktie (HIMS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Okupe Oluyemi | Chief Financial Officer |
Feb 03 '26 |
Sale |
26.44 |
5,262 |
139,108 |
91,617 |
| Okupe Oluyemi | Chief Financial Officer |
Jan 20 '26 |
Option Exercise |
6.27 |
9,067 |
56,836 |
100,684 |
| Okupe Oluyemi | Chief Financial Officer |
Jan 20 '26 |
Sale |
30.34 |
9,067 |
275,114 |
91,617 |
0.98%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):